Carotid Sinus Massage for Supraventricular Tachycardia
Carotid sinus massage should be performed as a first-line vagal maneuver in hemodynamically stable patients with narrow-complex SVT by applying steady pressure over the carotid sinus for 5-10 seconds after confirming absence of carotid bruit by auscultation, with the patient in the supine position. 1
How to Perform Carotid Sinus Massage
The 2015 ACC/AHA/HRS guidelines provide clear technical specifications 1:
- Patient positioning: Supine position is mandatory
- Pre-procedure assessment: Auscultate the carotid artery to confirm absence of bruit
- Technique: Apply steady pressure over the right OR left carotid sinus for 5-10 seconds
- Location: The carotid sinus is located at the bifurcation of the common carotid artery
- Sequential approach: If the first side fails, wait 1 minute, then attempt the opposite side
- Monitoring: Continuous ECG monitoring is required
Recent expert consensus recommends a standardized "Six-Step-Method" that includes checking contraindications, turning the head slightly contralaterally, palpating to identify the carotid sinus location, massaging for 10 seconds, monitoring hemodynamic response, and allowing time intervals between subsequent massages 2.
Efficacy Considerations
Carotid sinus massage has modest efficacy compared to other interventions. One study of 148 SVT patients showed Valsalva maneuver was more successful than carotid massage, with an overall success rate of only 27.7% when switching between techniques 1. More recent data suggests even lower success rates of approximately 18.5-20% for SVT termination 3, 4. In contrast, adenosine terminates AVNRT in approximately 95% of patients 1.
Absolute Contraindications
Do not perform carotid sinus massage in patients with:
- Carotid bruit on auscultation (unless carotid Doppler excludes ≥70% stenosis) 3, 5
- History of stroke or TIA within the past 3 months 3, 5
- Known significant carotid stenosis
- Previous ventricular tachyarrhythmia 5
- Recent myocardial infarction 5
Safety Profile and Complications
While generally safe, carotid sinus massage carries a 0.2-1% risk of neurological complications 3. A prospective study of 1,000 patients found transient neurological symptoms in 1% (visual disturbance, paresthesias, leg weakness), with persistent complications in only 0.1% of patients 5. The risk per individual massage episode is approximately 0.03% 5.
Common minor side effects include:
- Dizziness (3.5%)
- Vomiting (2.5%)
- Syncope (1.5%)
- Arrhythmia exacerbation (3.5%)
- Transient neurological symptoms (1%) 4
Clinical Algorithm
For hemodynamically stable narrow-complex SVT:
- First: Attempt Valsalva maneuver (bearing down against closed glottis for 10-30 seconds, generating 30-40 mmHg pressure) 1
- Second: If Valsalva fails, perform carotid sinus massage as described above
- Third: Administer adenosine (95% success rate) 1
- Fourth: Consider IV beta-blockers, diltiazem, or verapamil 1
- Last resort: Synchronized cardioversion if pharmacotherapy fails 1
For hemodynamically unstable patients: Skip vagal maneuvers entirely and proceed directly to synchronized cardioversion 1.
Important Caveats
- Never apply pressure to the eyeball - this practice is potentially dangerous and has been abandoned 1
- Carotid massage should NOT be performed bilaterally simultaneously
- The modified Valsalva maneuver has superior efficacy (43% vs ~20%) and no neurological complications, making it the preferred initial vagal maneuver 3
- In patients with accessory pathways (WPW), vagal maneuvers are still appropriate for orthodromic AVRT, but be prepared for potential precipitation of atrial fibrillation 1
- Equipment requirements: continuous blood pressure or cardiac monitoring, tilt table capability, and at least two persons present 2
The key clinical decision point: Given the modest efficacy (18.5-27.7%) and small but real neurological risk (0.2-1%), many experts now recommend proceeding directly to adenosine administration after a failed Valsalva maneuver, reserving carotid massage primarily for diagnostic evaluation of unexplained syncope rather than SVT termination 3.